Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Evaluated Smartwatches for Wellness Devotees - 2Chevron Says Damage at Wheatstone LNG Will Hamper Restart
- 3Comet Lemmon and Milky Way spotted over Hawaii | Space photo of the day for Dec. 12, 2025
- 4Passover under fire: Israelis balance fatigue with cautious hope after month of war
- 5Surprising links between autism, Alzheimer’s could change how we treat both
- Why Tourists May Want To Reconsider Traveling To This Popular Spot In Italy In 2026
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
- Instructions to Explore the Universe of Vehicle Leases
- Nordic people know how to beat the winter blues. Here's how to find light in the darkest months
- Far-right leader Le Pen to attend Brigitte Bardot's funeral
- Surging measles cases are 'fire alarm' warning that other diseases could be next
- Iran fires one of largest barrages in weeks ahead of Passover
- A top Marine shares his secrets to keeping fit at 50
- Flu concerns grow in US as UK sees more cases among kids
